Naveed Shams

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

Carl D. Regillo, David M. Brown, Prema Abraham et al. · American Journal of Ophthalmology · 2008 · 862 citations

Medicine, Ophthalmology, Surgery +10

Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration

Jeffrey S. Heier, Andrew N. Antoszyk, Peter R. Pavan et al. · Ophthalmology · 2006 · 361 citations

Medicine, Ophthalmology, Pharmacotherapy +10

Tolerability and Efficacy of Multiple Escalating Doses of Ranibizumab (Lucentis) for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, Jeffrey S. Heier, Gary Hantsbarger et al. · Ophthalmology · 2006 · 189 citations

Medicine, Ophthalmology, Pharmacology +12

Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension

Makoto Aihara, Fenghe Lu, Hisashi Kawata et al. · American Journal of Ophthalmology · 2020 · 100 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +14

Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study

Quan Dong Nguyen, Mohamed Ibrahim, Anthony Watters et al. · Journal of Ophthalmic Inflammation and Infection · 2013 · 95 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +9